Analyst Ratings for Medline Inc (MDLN)
MDLN Rating Summary
MDLN Price Target Summary
- Highest: $57.00 (UBS)
- Lowest: $38.00 (BNP Paribas Exane)
- Average: $50.81
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.81 (+15.9%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
Avg. $ Target:
$50.81 (+15.9%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/5/2026 | Tigress Financial Partners | Ivan Feinseth | New Coverage | Buy (N/A) |
55.00 (N/A) |
44.97 (43.83) |
-2.54% | Details |
| 1/12/2026 | Citi | Patrick Donnelly | New Coverage | Sell (N/A) |
48.00 (N/A) |
40.52 (43.83) |
8.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
